NOVERA RETATRUTIDE: A NEW SOLUTION FOR WEIGHT CONTROL?

Emerging clinical data suggests that Novera Retatrutide, a combined-action treatment from Novo Nordisk, could represent a substantial advance in weight control. Unlike many existing drugs, Retatrutide affects both GLP-1 and the GIP hormone, potentially resulting to improved losses in weight and p